Concepedia

Gregory Cairncross

GC

25

Publications

4.3K

Citations

20

H-Index

1994

Active since

Affiliations

University of Calgary(Current)

Western University

Mayo Clinic in Arizona

Mayo Clinic

University of Toronto

Gregory Cairncross is an author at University of Calgary specializing in medicine, glioma, and neuro-oncology.

Top concepts

Publications per year

1994–2020

25

Publications

25

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

Gregory Cairncross, Meihua Wang, Edward Shaw et al. · Journal of Clinical Oncology · 2012 · 1.1K citations · Full text

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Gregory Cairncross, Brian Berkey, Edward Shaw et al. · Journal of Clinical Oncology · 2006 · 724 citations

Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial

René-Olivier Mirimanoff, Thierry Gorlia, Warren Mason et al. · Journal of Clinical Oncology · 2006 · 505 citations

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

Gregory Cairncross, David Macdonald, Samuel K. Ludwin et al. · Journal of Clinical Oncology · 1994 · 442 citations

Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation.

C. Leighton, B. Fisher, Glenn Bauman et al. · Journal of Clinical Oncology · 1997 · 369 citations

Rows per page

1–5 of 25